Structures by: Gelbrich T.
Total: 305
(2<i>S</i>,3<i>R</i>,4<i>R</i>,5<i>S</i>,6<i>R</i>)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylsulfanyl)tetrahydro-2<i>H</i>-pyran-3,4,5-triol monohydrate
C21H25ClO5S,H2O
Acta Crystallographica Section C (2017) 73, 9
a=4.4659(3)Å b=9.8994(8)Å c=48.073(5)Å
α=90° β=90° γ=90°
C12H9BrINO2S
C12H9BrINO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=28.134(4)Å b=28.134(4)Å c=9.0240(18)Å
α=90.00° β=90.00° γ=120.00°
C12H9BrClNO2S
C12H9BrClNO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.045(4)Å b=27.045(4)Å c=9.1556(10)Å
α=90.00° β=90.00° γ=120.00°
C12H9ClINO2S
C12H9ClINO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.812(4)Å b=27.812(4)Å c=9.0055(18)Å
α=90.00° β=90.00° γ=120.00°
C13H9BrN2O2S
C13H9BrN2O2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.0722(8)Å b=27.0722(8)Å c=9.4838(8)Å
α=90.00° β=90.00° γ=120.00°
C13H9ClN2O2S
C13H9ClN2O2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=26.8055(15)Å b=26.8055(15)Å c=9.5489(6)Å
α=90.00° β=90.00° γ=120.00°
C13H9IN2O2S
C13H9IN2O2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.4867(7)Å b=27.4867(7)Å c=9.3972(7)Å
α=90.00° β=90.00° γ=120.00°
C12H9BrFNO2S
C12H9BrFNO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=26.5333(4)Å b=26.5333(4)Å c=9.2014(3)Å
α=90.00° β=90.00° γ=120.00°
C12H9ClFNO2S
C12H9ClFNO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=25.9241(8)Å b=25.9241(8)Å c=9.3533(5)Å
α=90.00° β=90.00° γ=120.00°
C12H9F2NO2S
C12H9F2NO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=24.9922(5)Å b=24.9922(5)Å c=9.5804(4)Å
α=90.00° β=90.00° γ=120.00°
C13H9BrF3NO2S
C13H9BrF3NO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=28.0220(6)Å b=28.0220(6)Å c=9.5386(3)Å
α=90.00° β=90.00° γ=120.00°
C13H9ClF3NO2S
C13H9ClF3NO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.805(3)Å b=27.805(3)Å c=9.4583(12)Å
α=90.00° β=90.00° γ=120.00°
C14H9F3N2O2S
C14H9F3N2O2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.6017(8)Å b=27.6017(8)Å c=9.4505(3)Å
α=90.00° β=90.00° γ=120.00°
C14H12N2O2S
C14H12N2O2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=26.9964(6)Å b=26.9964(6)Å c=9.5869(5)Å
α=90.00° β=90.00° γ=120.00°
C13H9F4NO2S
C13H9F4NO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.4403(4)Å b=27.4403(4)Å c=9.5034(3)Å
α=90.00° β=90.00° γ=120.00°
C12H9Cl1.8F0.2NO2S
C12H9Cl1.8F0.2NO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=26.4119(8)Å b=26.4119(8)Å c=9.3936(5)Å
α=90.00° β=90.00° γ=120.00°
Meta-schoepite
H16O20U4
Acta Crystallographica Section B (2000) 56, 4 577-583
a=14.6861(4)Å b=13.9799(3)Å c=16.7063(5)Å
α=90.00° β=90.00° γ=90.00°
C12H9FINO2S
C12H9FINO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.3131(5)Å b=27.3131(5)Å c=9.1331(2)Å
α=90.00° β=90.00° γ=120.00°
C13H12ClNO2S
C13H12ClNO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=26.7454(4)Å b=26.7454(4)Å c=9.5265(3)Å
α=90.00° β=90.00° γ=120.00°
C13H12INO2S
C13H12INO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.7443(14)Å b=27.7443(14)Å c=9.3639(9)Å
α=90.00° β=90.00° γ=120.00°
C12H9Cl2NO2S
C12H9Cl2NO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=26.5773(11)Å b=26.5773(11)Å c=9.3206(4)Å
α=90.00° β=90.00° γ=120.00°
C13H12INO3S
C13H12INO3S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.3759(8)Å b=27.3759(8)Å c=9.9002(4)Å
α=90.00° β=90.00° γ=120.00°
C13H12BrNO2S
C13H12BrNO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.1912(10)Å b=27.1912(10)Å c=9.4503(7)Å
α=90.00° β=90.00° γ=120.00°
C14H12F3NO2S
C14H12F3NO2S
Acta Crystallographica Section B (2007) 63, 4 621-632
a=27.7243(7)Å b=27.7243(7)Å c=9.8101(5)Å
α=90.00° β=90.00° γ=120.00°
Febuxostat ethanol monosolvate
C16H16N2O3S,C2H6O
Acta Crystallographica Section E (2020) 76, 6 816-819
a=4.7274(2)Å b=17.7820(5)Å c=10.7340(4)Å
α=90° β=98.994(4)° γ=90°
1,3-Dimethoxy-2-(methylsulfanyl)imidazolium tetrafluoridoborate
C6H11N2O2S,BF4
Acta Crystallographica Section E (2020) 76, 4 552-556
a=8.1049(7)Å b=11.6979(10)Å c=12.0810(12)Å
α=90° β=90.069(9)° γ=90°
1,3-Dibenzyloxy-2-(methylsulfanyl)imidazolium tetrafluoridoborate
C18H19N2O2S,BF4
Acta Crystallographica Section E (2020) 76, 4 552-556
a=7.9117(3)Å b=11.4760(4)Å c=20.9659(7)Å
α=90° β=90° γ=90°
3-Bromo-4-dimethylamino-1-methyl-1,2,4-triazol-5(4<i>H</i>)-one
C5H9BrN4O
Acta Crystallographica Section E (2015) 71, 1 o23
a=15.1993(6)Å b=6.9377(4)Å c=7.8771(7)Å
α=90° β=93.869(3)° γ=90°
Methohexital
C14H18N2O3
Acta Crystallographica Section E (2015) 71, 2 206-209
a=7.7502(6)Å b=7.9792(5)Å c=12.6881(10)Å
α=93.713(6)° β=96.226(6)° γ=113.314(7)°
3-Bromo-2-hydroxybenzoic acid
C7H5BrO3
Acta Crystallographica Section E (2015) 71, 5 531-535
a=3.7978(4)Å b=10.5567(6)Å c=18.0366(10)Å
α=90° β=90.208(7)° γ=90°
Naloxegol hydrogen oxalate
C34H54NO11,C2HO4
Acta Crystallographica Section E (2018) 74, 4 474-477
a=10.35810(10)Å b=13.40390(10)Å c=26.1689(2)Å
α=90° β=90° γ=90°
Idelalisib t-BuOH monosolvate dihydrate
C22H18FN7O,C4H10O,2(H2O)
Acta Crystallographica Section E (2019) 75, 3 414-417
a=21.3758(6)Å b=9.2781(3)Å c=13.9722(5)Å
α=90° β=102.654(3)° γ=90°
5-Hydroxy-5-propylbarbituric acid
C7H10N2O4
Acta Crystallographica Section E (2015) 71, 11 1311-1314
a=10.7862(8)Å b=6.7093(5)Å c=11.7365(6)Å
α=90° β=98.632(6)° γ=90°
Buthalital (Bayinal, Baytinal, Thialbutal, Transithal, Ulbreval)
C11H16N2O2S
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1908-1912
a=8.7271(6)Å b=11.6521(4)Å c=12.5400(8)Å
α=90° β=96.539(2)° γ=90°
Methitural (Neraval, Thiogenal)
C12H20N2O2S2
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 12 1908-1912
a=15.1873(2)Å b=9.09200(10)Å c=20.8684(3)Å
α=90° β=96.0830(10)° γ=90°
(<i>E</i>)-2,6-Dibromo-4-{2-[1-(1<i>H</i>,1<i>H</i>,2<i>H</i>,2<i>H</i>-perfluorooctyl)pyridinium-4-yl]ethenyl}phenolate methanol disolvate
C21H12Br2F13NO,2(CH4O)
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 10 1526-1529
a=22.2362(7)Å b=6.7922(18)Å c=18.9098(5)Å
α=90° β=103.989(3)° γ=90°
I>cis</i>-Diamminebis(nitrito-κ<i>N</i>)platinum(II)
H6N4O4Pt
Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 4 366-370
a=6.8656(5)Å b=12.6428(8)Å c=7.0931(5)Å
α=90° β=110.579(8)° γ=90°
(1S*,4S*,5R*,8R*)-4,8-Diphenyl-3,7-dioxabicyclo[3.3.0]octan-2-one
C18H16O3
Acta Crystallographica Section E (2001) 57, 7 o566-o567
a=21.4160(10)Å b=7.5200(10)Å c=19.4870(10)Å
α=90.00° β=117.860(10)° γ=90.00°
C8H16N2O4
C8H16N2O4
Acta Crystallographica Section E (2001) 57, 8 o796-o797
a=8.0299(16)Å b=12.765(3)Å c=10.587(2)Å
α=90.00° β=92.11(3)° γ=90.00°
C26H20S8
C26H20S8
Acta Crystallographica Section E (2001) 57, 12 o1143-o1144
a=27.083(2)Å b=10.0911(10)Å c=20.304(2)Å
α=90.00° β=110.212(3)° γ=90.00°
Bis(trimetylamine) aluminiumtrichloride
C6H18AlCl3N2
Acta Crystallographica Section C (1999) 55, 11 1797-1798
a=9.645(8)Å b=9.994(2)Å c=12.918(6)Å
α=90.00° β=90.00° γ=90.00°
Cyclo-tri-μ-methoxo-tris(dichloroaluminium)
C3H9Al3Cl6O3
Acta Crystallographica Section C (1999) 55, 6 856-858
a=10.5030(10)Å b=13.889(2)Å c=10.6780(10)Å
α=90.00° β=90.68(2)° γ=90.00°
Alogliptin
C18H21N5O2
Acta Crystallographica Section C (2013) 69, 6 674-678
a=8.4528(5)Å b=8.5689(5)Å c=12.4424(7)Å
α=87.840(5)° β=72.284(5)° γ=87.368(8)°
Alogliptin benzoate
C18H22N5O2,C7H5O2
Acta Crystallographica Section C (2013) 69, 6 674-678
a=8.0666(2)Å b=9.8727(2)Å c=28.4593(6)Å
α=90° β=90° γ=90°
4-amino-<i>N</i>-(2-pyridyl)benzenesulfonamide
C11H11N3O2S
Acta Crystallographica Section C (2007) 63, 6 o323-o326
a=10.827(2)Å b=14.932(3)Å c=15.486(3)Å
α=90.00° β=110.07(3)° γ=90.00°
5-Cyclohexyl-5-ethylbarbituric acid form I
C12H18N2O3
Acta Crystallographica Section C (2015) 71, 3
a=17.9322(4)Å b=10.4961(3)Å c=13.2006(4)Å
α=90° β=95.896(2)° γ=90°
5-Cyclohexyl-5-ethylbarbituric acid form II
C12H18N2O3
Acta Crystallographica Section C (2015) 71, 3
a=12.5071(7)Å b=21.0741(9)Å c=10.3310(5)Å
α=90° β=116.989(5)° γ=90°
Sulfasymazine
C13H17N5O2S
Acta Crystallographica Section C (2008) 64, 6 o309-o312
a=9.3257(2)Å b=16.7918(4)Å c=9.8600(2)Å
α=90.00° β=110.6930(10)° γ=90.00°
Sulfatriazine
C11H13N5O4S
Acta Crystallographica Section C (2008) 64, 6 o309-o312
a=8.1566(3)Å b=8.6577(4)Å c=10.5410(4)Å
α=97.180(3)° β=103.374(2)° γ=109.255(2)°
Narconumal, Enallylpropymal
C11H16N2O3
Acta Crystallographica Section C (2010) 66, 1 o55-o58
a=6.4160(7)Å b=7.9559(8)Å c=11.9569(12)Å
α=77.574(7)° β=80.837(7)° γ=75.518(6)°
1,5-di(but-2-enyl)-5-ethylbarbituric acid
C14H20N2O3
Acta Crystallographica Section C (2010) 66, 1 o55-o58
a=10.2825(11)Å b=13.2972(16)Å c=10.3959(10)Å
α=90° β=92.999(7)° γ=90°
4-Cyano-<i>N</i>-(4-methoxyphenyl)benzenesulfonamide
C14H12N2O3S
Acta Crystallographica Section C (2012) 68, 10 o421-o426
a=22.0249(7)Å b=12.5626(5)Å c=5.05120(10)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(4-Methoxyphenyl)-4-(trifluoromethyl)benzenesulfonamide
C14H12F3NO3S
Acta Crystallographica Section C (2012) 68, 10 o421-o426
a=22.1833(14)Å b=12.8024(8)Å c=5.0114(3)Å
α=90.00° β=90.00° γ=90.00°
4-Iodo-<i>N</i>-(4-methoxyphenyl)benzenesulfonamide
C13H12INO3S
Acta Crystallographica Section C (2012) 68, 10 o421-o426
a=21.6853(8)Å b=12.6570(5)Å c=5.0586(3)Å
α=90.00° β=90.00° γ=90.00°
4-Bromo-<i>N</i>-(4-methoxyphenyl)benzenesulfonamide
C13H12BrNO3S
Acta Crystallographica Section C (2012) 68, 10 o421-o426
a=21.6210(7)Å b=12.3720(3)Å c=5.05260(10)Å
α=90.00° β=90.00° γ=90.00°
4-Chloro-<i>N</i>-(4-methoxyphenyl)benzenesulfonamide
C13H12ClNO3S
Acta Crystallographica Section C (2012) 68, 10 o421-o426
a=21.2580(15)Å b=12.3967(5)Å c=5.0526(3)Å
α=90.00° β=90.00° γ=90.00°
4-Fluoro-<i>N</i>-(4-methoxyphenyl)benzenesulfonamide
C13H12FNO3S
Acta Crystallographica Section C (2012) 68, 10 o421-o426
a=20.7242(4)Å b=12.3551(4)Å c=5.02090(10)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-(4-Chlorophenyl)-4-methoxybenzenesulfonamide
C13H12ClNO3S
Acta Crystallographica Section C (2012) 68, 10 o421-o426
a=21.3923(7)Å b=12.3691(4)Å c=5.0386(2)Å
α=90.00° β=90.00° γ=90.00°
4-Cyano-<i>N</i>-phenylbenzenesulfonamide
C13H10N2O2S
Acta Crystallographica Section C (2012) 68, 10 o421-o426
a=20.1912(7)Å b=12.0001(4)Å c=5.10550(10)Å
α=90.00° β=90.00° γ=90.00°
Telaprevir
C36H53N7O6
Acta Crystallographica Section C (2013) 69, 2 179-182
a=10.4235(2)Å b=19.1651(2)Å c=37.2907(4)Å
α=90.00° β=90.00° γ=90.00°
Codeine hydrogen dihydrogen phosphate hemihydrate
C18H22NO3,H2O4P,0.5H2O
Acta Crystallographica Section C (2009) 65, 8 o419-o422
a=6.9113(2)Å b=33.4470(9)Å c=8.0716(2)Å
α=90.00° β=99.778(3)° γ=90.00°
Anilinium chloride--N-phenyl-4-bromobenzenesulfonamide (1/1)
C6H8N,Cl,C12H10BrNO2S
Acta Crystallographica Section C (2006) 62, 8 o470-o472
a=5.6705(4)Å b=9.9954(7)Å c=17.3234(12)Å
α=83.137(4)° β=81.655(4)° γ=77.163(3)°
Acemetacin monohydrate
C21H18ClNO6,H2O
Acta Crystallographica Section C (2007) 63, 8 o451-o453
a=7.7257(3)Å b=10.2208(3)Å c=13.4225(4)Å
α=96.879(2)° β=96.354(2)° γ=107.158(2)°
Trans-4-[4-(Dimethylamino)phenyliminomethyl]-N-phenylpyridinium hexafluorophosphate
C20H20N3,PF6
Acta Crystallographica Section C (2000) 56, 12 1487-1489
a=19.3044(4)Å b=10.6009(3)Å c=11.6549(3)Å
α=90.00° β=125.527(2)° γ=90.00°
Butobarbital
C10H16N2O3
Acta Crystallographica Section C (2007) 63, 12 o751-o753
a=6.85340(10)Å b=29.6631(7)Å c=22.2107(5)Å
α=90.00° β=94.4080(10)° γ=90.00°
Δ-Sulfanilamide
C6H8N2O2S
Acta Crystallographica Section C (2008) 64, 4 o205-o207
a=9.7056(19)Å b=8.6794(17)Å c=17.890(4)Å
α=90.00° β=90.00° γ=90.00°
Plumeridoid C
C15H18O7
Acta Crystallographica Section C (2011) 67, 10 o409-o412
a=9.6736(2)Å b=7.62030(10)Å c=10.6303(2)Å
α=90.00° β=107.142(2)° γ=90.00°
Eldoral
C11H17N3O3
Acta Crystallographica Section C (2012) 68, 2 o65-o70
a=7.8761(2)Å b=12.7102(4)Å c=11.9438(3)Å
α=90.00° β=98.189(3)° γ=90.00°
Eldoral
C11H17N3O3
Acta Crystallographica Section C (2012) 68, 2 o65-o70
a=11.9311(3)Å b=15.9858(4)Å c=13.0768(3)Å
α=90.00° β=106.7990(10)° γ=90.00°
Diethylammonium 5-ethyl-2,4,6-trioxo-5-(piperidin-1-yl)-1,3-diazinan-1-ide
C4H12N,C11H16N3O3
Acta Crystallographica Section C (2012) 68, 2 o65-o70
a=11.8270(3)Å b=16.1719(4)Å c=18.6774(5)Å
α=90.00° β=90.00° γ=90.00°
Diphenylmethanesulfonamide
C13H14N2O4S2
Acta Crystallographica Section E (2010) 66, 7 o1619
a=10.8251(5)Å b=5.0791(3)Å c=12.6912(5)Å
α=90° β=90.931(3)° γ=90°
Polythiazide
C11H13ClF3N3O4S3
Acta Crystallographica Section E (2010) 66, 7 o1663-o1664
a=14.6659(7)Å b=9.5498(6)Å c=13.6720(7)Å
α=90.00° β=116.149(3)° γ=90.00°
Butallylonal 1,4-dioxane hemisolvate
C11H15BrN2O3,0.5(C4H8O2)
Acta Crystallographica Section E (2010) 66, 10 o2688
a=10.494(2)Å b=6.7679(8)Å c=21.864(3)Å
α=90.00° β=97.294(15)° γ=90.00°
5,5-dihydroxybarbituric acid 1,4-dioxane hemisolvate
C4H4N2O5,0.5(C4H8O2)
Acta Crystallographica Section E (2010) 66, 5 o1219
a=6.0232(3)Å b=8.3954(4)Å c=8.6858(5)Å
α=106.007(4)° β=94.459(3)° γ=110.126(3)°
Proseptazine
C13H14N2O2S
Acta Crystallographica Section E (2011) 67, 6 o1551-o1552
a=7.84260(10)Å b=10.5549(11)Å c=14.6694(3)Å
α=90.00° β=90.00° γ=90.00°
Morphine
C17H19NO3
Acta Crystallographica Section E (2013) 69, 1 o2
a=7.6989(10)Å b=12.737(4)Å c=13.740(4)Å
α=90.00° β=90.00° γ=90.00°
Gliquidone
C27H33N3O6S
Acta Crystallographica Section E (2011) 67, 6 o1343
a=19.1494(4)Å b=10.7253(3)Å c=13.8024(2)Å
α=90.00° β=106.6910(10)° γ=90.00°
5,5-dichlorobarbituric acid
C4H2Cl2N2O3
Acta Crystallographica Section E (2012) 68, 1 o235-o236
a=13.8883(3)Å b=13.8883(3)Å c=6.9126(2)Å
α=90.00° β=90.00° γ=90.00°
Morphine hydrochloride anhydrate
C17H20NO3,Cl
Acta Crystallographica Section E (2012) 68, 12 o3358-o3359
a=7.3504(2)Å b=12.8524(5)Å c=16.0372(5)Å
α=90.00° β=90.00° γ=90.00°
C23H26HgN4S2,2(ClO4)
C23H26HgN4S2,2(ClO4)
Inorganic Chemistry (2007) 46, 4548-4559
a=22.199(2)Å b=8.7307(5)Å c=28.982(2)Å
α=90.00° β=98.407(2)° γ=90.00°
C21H23Cl2N3O8PbS2
C21H23Cl2N3O8PbS2
Inorganic Chemistry (2007) 46, 4548-4559
a=9.4031(8)Å b=20.719(2)Å c=12.8426(11)Å
α=90.00° β=90.956(2)° γ=90.00°
Cu(C21H22ClN3O1S2)22,2(BF4),2(CH3NO2)
Cu(C21H22ClN3O1S2)22,2(BF4),2(CH3NO2)
Inorganic Chemistry (2007) 46, 4548-4559
a=6.7570(17)Å b=25.205(6)Å c=15.048(4)Å
α=90.00° β=100.38(2)° γ=90.00°
C21H25Cl2N3O9S2Zn
C21H25Cl2N3O9S2Zn
Inorganic Chemistry (2007) 46, 4548-4559
a=12.3734(10)Å b=14.1375(12)Å c=14.9149(12)Å
α=90.00° β=96.326(1)° γ=90.00°
C51H47Cl3Cu3N7O3S4,3(ClO4),7.5(H2O)
C51H47Cl3Cu3N7O3S4,3(ClO4),7.5(H2O)
Inorganic Chemistry (2007) 46, 4548-4559
a=12.297(3)Å b=17.199(4)Å c=17.234(4)Å
α=116.069(4)° β=104.143(4)° γ=91.725(4)°
C21H23CuN3S2,2(ClO4),0.5(C2H3N)
C21H23CuN3S2,2(ClO4),0.5(C2H3N)
Inorganic Chemistry (2007) 46, 4548-4559
a=11.8164(12)Å b=14.494(2)Å c=15.890(2)Å
α=90.00° β=108.924(2)° γ=90.00°
C4H7I2NS2
C4H7I2NS2
Crystal Growth & Design (2007) 7, 7 1284
a=16.121(2)Å b=5.950(1)Å c=13.105(1)Å
α=90.00° β=127.53(1)° γ=90.00°
C4H7BrINS2
C4H7BrINS2
Crystal Growth & Design (2007) 7, 7 1284
a=15.6865(14)Å b=5.8068(7)Å c=12.6748(14)Å
α=90.00° β=126.190(9)° γ=90.00°
C4H7BrINS2
C4H7BrINS2
Crystal Growth & Design (2007) 7, 7 1284
a=14.746(3)Å b=18.417(9)Å c=12.542(4)Å
α=90.00° β=123.96(2)° γ=90.00°
C7H5N3O6
C7H5N3O6
Crystal Growth & Design (2003) 3, 6 1027
a=14.9113(1)Å b=6.0340(1)Å c=20.8815(3)Å
α=90.00° β=110.365(1)° γ=90.00°
C7H5N3O6
C7H5N3O6
Crystal Growth & Design (2003) 3, 6 1027
a=14.910(2)Å b=6.0341(18)Å c=19.680(4)Å
α=90.00° β=90.00° γ=90.00°
Methyl paraben
C8H8O3
Crystal growth & design (2013) 13, 3 1206-1217
a=4.8980(8)Å b=14.698(2)Å c=10.3341(16)Å
α=90.00° β=98.774(4)° γ=90.00°
Methyl paraben
C8H8O3
Crystal growth & design (2013) 13, 3 1206-1217
a=17.517(5)Å b=7.2602(18)Å c=6.224(2)Å
α=90.00° β=107.61(3)° γ=90.00°
Methyl paraben
C8H8O3
Crystal growth & design (2013) 13, 3 1206-1217
a=5.9845(6)Å b=8.3384(6)Å c=14.4209(12)Å
α=90.00° β=96.526(9)° γ=90.00°
C6H13NO2
C6H13NO2
Crystal Growth & Design (2009) 9, 11 4610
a=34.171(3)Å b=4.8197(3)Å c=9.8356(7)Å
α=90.00° β=101.054(3)° γ=90.00°
C6H13NO2
C6H13NO2
Crystal Growth & Design (2009) 9, 11 4610
a=31.2955(9)Å b=4.72660(10)Å c=9.8803(3)Å
α=90.00° β=91.870(2)° γ=90.00°
C6H13NO2
C6H13NO2
Crystal Growth & Design (2009) 9, 11 4610
a=16.5130(8)Å b=4.7740(2)Å c=9.9245(4)Å
α=90.00° β=102.338(3)° γ=90.00°
C25H32N2O3
C25H32N2O3
Inorganic chemistry (2007) 46, 19 8088-8097
a=13.3963(13)Å b=12.3062(12)Å c=13.4509(13)Å
α=90.00° β=93.300(2)° γ=90.00°
C50H67Cl3N4O18
C50H67Cl3N4O18
Inorganic chemistry (2007) 46, 19 8088-8097
a=10.3932(10)Å b=11.8701(11)Å c=12.1822(12)Å
α=99.017(2)° β=98.096(1)° γ=113.352(1)°
C25H32CdN4O9
C25H32CdN4O9
Inorganic chemistry (2007) 46, 19 8088-8097
a=10.0206(5)Å b=7.8827(4)Å c=32.782(3)Å
α=90.00° β=92.210(5)° γ=90.00°
C37H39Au2Cl2NO3P2
C37H39Au2Cl2NO3P2
CrystEngComm (2006) 8, 2 140
a=11.2658(10)Å b=11.6465(2)Å c=14.4950(2)Å
α=85.708(1)° β=74.044(1)° γ=86.088(1)°